Mojgan Djavaheri-Mergny PhD Pharmacology
Course and current status
2019-present : CRHC INSERM research scientist, Centre de recherche des Cordeliers Paris, France.
2009-2018 : CR1 INSERM research scientist, institut Bergonié, Bordeaux, France.
2003-2009 : CR1 INSERM research scientist, hôpital Paul brousse, Villejuif, France.
2008 : Habilitation à Diriger la recherche (HDR), University of PARIS XI, France.
1999-2003 : CR1 INSERM research scientist, Institut Curie, Paris, France.
1995-1999 : CR2 INSERM research scientist, Hôpital Saint-Louis, Paris, France.
1993-1995 : Post-doctoral fellow, CNRS-Aventis, Vitry-Sur Seine, France.
1990-1993: Ph.D in Pharmacology, University PARIS XI, France.
Scientific summary
Lysosome signaling in cancer
The aim of our group is to characterize the molecular connections between lysosome signaling, programmed cell death pathways and differentiation in the context of cancer cells.
